These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient. Ozen S; Demir S Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352 [TBL] [Abstract][Full Text] [Related]
5. The fresco of autoinflammatory diseases from the pediatric perspective. Rigante D Autoimmun Rev; 2012 Mar; 11(5):348-56. PubMed ID: 22024500 [TBL] [Abstract][Full Text] [Related]
6. Autoinflammatory syndromes: fever is not always a sign of infection. Zeft AS; Spalding SJ Cleve Clin J Med; 2012 Aug; 79(8):569-81. PubMed ID: 22854436 [TBL] [Abstract][Full Text] [Related]
7. The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples. Oldham J; Lachmann HJ Clin Exp Dermatol; 2020 Dec; 45(8):967-973. PubMed ID: 32882069 [TBL] [Abstract][Full Text] [Related]
8. Autoinflammatory Diseases with Periodic Fevers. Sag E; Bilginer Y; Ozen S Curr Rheumatol Rep; 2017 Jul; 19(7):41. PubMed ID: 28631068 [TBL] [Abstract][Full Text] [Related]
9. The Eurofever Project: towards better care for autoinflammatory diseases. Ozen S; Frenkel J; Ruperto N; Gattorno M; Eur J Pediatr; 2011 Apr; 170(4):445-52. PubMed ID: 21360011 [TBL] [Abstract][Full Text] [Related]
10. Treatment of hereditary autoinflammatory diseases. Ter Haar NM; Frenkel J Curr Opin Rheumatol; 2014 May; 26(3):252-8. PubMed ID: 24667287 [TBL] [Abstract][Full Text] [Related]
11. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome. van der Meer JW; Simon A Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii23-ii29. PubMed ID: 27856657 [TBL] [Abstract][Full Text] [Related]
12. Autoinflammatory conditions: when to suspect? How to treat? Grateau G; Duruöz MT Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):401-11. PubMed ID: 20534373 [TBL] [Abstract][Full Text] [Related]
13. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron KS; Benseler S; Berard R; Broderick L; Dedeoglu F; Diebold M; Durrant KL; Ferguson P; Foell D; Hausmann J; Jones OY; Kastner DL; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman H; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E Ann Rheum Dis; 2022 Jul; 81(7):907-921. PubMed ID: 35623638 [TBL] [Abstract][Full Text] [Related]
14. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist. Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron K; Benseler S; Berard RA; Broderick L; Dedeoglu F; Diebold M; Durrant K; Ferguson P; Foell D; Hausmann JS; Jones OY; Kastner D; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman HM; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E Arthritis Rheumatol; 2022 Jul; 74(7):1102-1121. PubMed ID: 35621220 [TBL] [Abstract][Full Text] [Related]